These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 32383980)
41. Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine. Kim K; Ku CR; Lee EJ Endocrinol Metab (Seoul); 2023 Oct; 38(5):463-471. PubMed ID: 37828709 [TBL] [Abstract][Full Text] [Related]
42. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma. Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133 [TBL] [Abstract][Full Text] [Related]
43. Visual Analytics for Hypothesis-Driven Exploration in Computational Pathology. Corvo A; Caballero HSG; Westenberg MA; van Driel MA; van Wijk JJ IEEE Trans Vis Comput Graph; 2021 Oct; 27(10):3851-3866. PubMed ID: 32340951 [TBL] [Abstract][Full Text] [Related]
44. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas. Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770 [TBL] [Abstract][Full Text] [Related]
45. ExpOmics: a comprehensive web platform empowering biologists with robust multi-omics data analysis capabilities. Li D; Min Z; Guo J; Chen Y; Zhang W Bioinformatics; 2024 Aug; 40(8):. PubMed ID: 39128019 [TBL] [Abstract][Full Text] [Related]
46. Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma. Hu LS; Wang L; Hawkins-Daarud A; Eschbacher JM; Singleton KW; Jackson PR; Clark-Swanson K; Sereduk CP; Peng S; Wang P; Wang J; Baxter LC; Smith KA; Mazza GL; Stokes AM; Bendok BR; Zimmerman RS; Krishna C; Porter AB; Mrugala MM; Hoxworth JM; Wu T; Tran NL; Swanson KR; Li J Sci Rep; 2021 Feb; 11(1):3932. PubMed ID: 33594116 [TBL] [Abstract][Full Text] [Related]
47. Revealing transcriptional and post-transcriptional regulatory mechanisms of γ-glutamyl transferase and keratin isoforms as novel cooperative biomarkers in low-grade glioma and glioblastoma multiforme. Mottaghitalab F; Lanjanian H; Masoudi-Nejad A Genomics; 2021 Jul; 113(4):2623-2633. PubMed ID: 34118380 [TBL] [Abstract][Full Text] [Related]
48. GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis. Yang Y; Sui Y; Xie B; Qu H; Fang X Genomics Proteomics Bioinformatics; 2019 Aug; 17(4):465-471. PubMed ID: 31811943 [TBL] [Abstract][Full Text] [Related]
49. Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes. Chen Y; Gao Z; Wang B; Xu R BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):516. PubMed ID: 27557118 [TBL] [Abstract][Full Text] [Related]
50. Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction. Zhou M; Chaudhury B; Hall LO; Goldgof DB; Gillies RJ; Gatenby RA J Magn Reson Imaging; 2017 Jul; 46(1):115-123. PubMed ID: 27678245 [TBL] [Abstract][Full Text] [Related]
51. Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas. Wang J; Ma J J Neurol Surg A Cent Eur Neurosurg; 2019 Jul; 80(4):240-249. PubMed ID: 30934097 [TBL] [Abstract][Full Text] [Related]
52. Integrative network-based Bayesian analysis of diverse genomics data. Wang W; Baladandayuthapani V; Holmes CC; Do KA BMC Bioinformatics; 2013; 14 Suppl 13(Suppl 13):S8. PubMed ID: 24267288 [TBL] [Abstract][Full Text] [Related]
53. DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas. Han MH; Baek JM; Min KW; Cheong JH; Ryu JI; Won YD; Kwon MJ; Koh SH BMC Neurol; 2023 May; 23(1):183. PubMed ID: 37149563 [TBL] [Abstract][Full Text] [Related]
54. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis. Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116 [TBL] [Abstract][Full Text] [Related]
55. Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer. Li R; Wang S; Cui Y; Qu H; Chater JM; Zhang L; Wei J; Wang M; Xu Y; Yu L; Lu J; Feng Y; Zhou R; Huang Y; Ma R; Zhu J; Zhong W; Jia Z Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32898860 [TBL] [Abstract][Full Text] [Related]
56. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients. Nicolasjilwan M; Hu Y; Yan C; Meerzaman D; Holder CA; Gutman D; Jain R; Colen R; Rubin DL; Zinn PO; Hwang SN; Raghavan P; Hammoud DA; Scarpace LM; Mikkelsen T; Chen J; Gevaert O; Buetow K; Freymann J; Kirby J; Flanders AE; Wintermark M; J Neuroradiol; 2015 Jul; 42(4):212-21. PubMed ID: 24997477 [TBL] [Abstract][Full Text] [Related]
57. Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery. Zhang S; Deshpande A; Verma BK; Wang H; Mi H; Yuan L; Ho WJ; Jaffee EM; Zhu Q; Anders RA; Yarchoan M; Kagohara LT; Fertig EJ; Popel AS Cancer Res; 2024 Aug; 84(16):2734-2748. PubMed ID: 38861365 [TBL] [Abstract][Full Text] [Related]
58. A quantitative model based on clinically relevant MRI features differentiates lower grade gliomas and glioblastoma. Cao H; Erson-Omay EZ; Li X; Günel M; Moliterno J; Fulbright RK Eur Radiol; 2020 Jun; 30(6):3073-3082. PubMed ID: 32025832 [TBL] [Abstract][Full Text] [Related]
60. Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts. Li D; Li S; Xue AZ; Smith Callahan LA; Liu Y Medicine (Baltimore); 2020 Mar; 99(12):e18815. PubMed ID: 32195924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]